Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01733758Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- Jun 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Feb 2013; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01733758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733758.